Bicara Therapeutics BCAX Permanent differences
Permanent differences at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept bcax:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent.
The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's permanent differences.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bicara Therapeutics's permanent differences?
- Bicara Therapeutics (BCAX) reported permanent differences of -0.5% in Q4 2024.
- What does permanent differences mean?
- This metric identifies the impact of permanent differences between financial reporting income and taxable income that will not reverse in future periods. These differences arise from specific accounting treatments or tax regulations that do not align with GAAP. It is essential for understanding the structural gap between the statutory tax rate and the actual effective tax rate.